Late Breaking News
WASHINGTON, DC—Finding innovative research vectors for major diseases, furthering partnerships with industry, and ironing out conflicts of interest among scientists are some of the many pressing goals facing NIH. Testifying before Congress last month, NIH Director Francis Collins, MD, PhD, discussed those issues, as well as how the agency allocates its research dollars.
WASHINGTON, DC—The FDA is in need of a conceptual framework to help the agency evaluate the ethical issues involved in determining whether companies should start or continue clinical trials on approved drugs and in ensuring that these studies are ethically conducted, according to an IoM report released last month.
WASHINGTON, DC—Many federal physicians do not feel they are adequately paid, but also may not be aware of the pay policies of their respective agencies, a survey conducted by the Federal Physicians Association (FPA) found.
WASHINGTON, DC—Suicide surveillance technology is helping the military track suicides, an important component in prevention, officials said during a DCoE webinar held last month.
INDIANAPOLIS, IN—The paradigm of schizophrenia treatment through most of the 20th century was a relatively simple one. The disease could be managed with drugs or therapy, many times on an inpatient basis at a hospital facility, but therapy provided little hope.
BETHESDA, MD—Few youths with early-onset schizophrenia who are treated with antipsychotic medications for up to a year appear to benefit from their initial treatment choice over the long term, according to results from an NIMH-funded study. The study was published online in the Journal of the American Academy of Child and Adolescent Psychiatry.
WASHINGTON, DC—While the nation’s attention is heavily focused on the treatment of war-related mental health issues, military providers are also busy caring for those psychiatric conditions that may not be war related.
BETHESDA, MD—Treating a complex disease like schizophrenia is difficult, and that difficulty is only compounded when it comes to prescribing medications to treat the disease. The antipsychotics generally used to treat schizophrenia are accompanied by a variety of sometimes-powerful, often inconvenient, side effects.
Schizophrenia is a chronic and incapacitating brain disorder that impacts both the patient with the condition and those who must care for them.
PLANS TO DEVELOP A FULLY AUTOMATED ONLINE CLAIMS SYSTEM for handling veterans’ disability compensation claims was announced by VA last month. According to the agency, the system will be more than a simple digitization of existing paper-based claims. It is designed to substantially reduce processing time and increase accuracy while simplifying the way that veterans interact with the claims process.
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List